Jazz Pharmaceuticals has patented a CBD preparation with over 90% CBD and a specific ratio of THC is more effective in treating diseases. The presence of minor impurities like THC enhances the efficacy of CBD treatment, providing a synergistic effect. GlobalData’s report on Jazz Pharmaceuticals gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Jazz Pharmaceuticals Plc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Jazz Pharmaceuticals, Cancer treatment biomarkers was a key innovation area identified from patents. Jazz Pharmaceuticals's grant share as of February 2024 was 47%. Grant share is based on the ratio of number of grants to total number of patents.

Cbd preparation with at least 90% cbd and thc

Source: United States Patent and Trademark Office (USPTO). Credit: Jazz Pharmaceuticals Plc

A recently granted patent (Publication Number: US11865102B2) discloses a cannabidiol (CBD) preparation with a high concentration of CBD, greater than or equal to 90% (w/w) based on the total amount of cannabinoids in the preparation. The remaining cannabinoids in the preparation include tetrahydrocannabinol (THC), present as a mixture of trans-THC and cis-THC, with a specific ratio ranging from about 0.7:1.0 to about 5.0:1.0. Additionally, the CBD preparation contains not more than 1.5% (w/w) THC, with specific ranges of THC content specified in the claims.

Furthermore, the patent covers the use of this CBD preparation in pharmaceutical compositions for treating epilepsy, specifically targeting conditions such as Dravet syndrome, Lennox Gastaut syndrome, Doose syndrome, or tuberous sclerosis complex (TSC). The method involves administering a therapeutically effective amount of the CBD preparation, with specified dosage ranges from about 5 mg/kg/day to about 50 mg/kg/day for different epilepsy conditions. The patent also includes provisions for the preparation of cannabinoids from cannabis plant material or synthetically, highlighting the versatility and potential applications of the disclosed CBD preparation in the medical field.

To know more about GlobalData’s detailed insights on Jazz Pharmaceuticals, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies